HIV and HCV Intervention In Drug Treatment Settings - 1

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Behavior Therapy

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Denver Health & Hosp Authority, Denver, Colorado, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Volunteers will be IV drug users already enrolled in drug detoxification treatment.

Treatment and study plan

Behavior Therapy

Behavioral

Primary outcomes

HIV/HCV injection risk behaviors

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

Oregon Health and Science University

Registry information

Official study title

HIV and HCV Intervention in Drug Treatment Settings

Important dates

Study start: 2004
Primary completion: 2006
Study completion: 2006
First posted: Jan 28, 2005
Registry last updated: Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed